We are live on ! Find out more
ASLN

ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN

Delisted

ASLN was delisted on the 18th of July, 2024.

Back to rankings

1 hedge funds and large institutions have $95 invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2024 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more capital invested

Capital invested by funds: $95 → $95 ($0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
1
RhumbLine Advisers
Massachusetts
$95 – – –

ASLN Hedge Fund Activity: Q4 2024 in Review

1 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) for Q4 2024, worth a combined $95 — unchanged from a quarter earlier.

Fund positioning in ASLN was balanced in Q4 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $95 of ASLAN Pharmaceuticals Limited American Depositary Shares stock for Q4 2024, unchanged quarter-over-quarter.
  • 0 funds opened new ASLAN Pharmaceuticals Limited American Depositary Shares positions in Q4 2024 and 0 closed out.

Based on aggregated 13F filings for Q4 2024.